EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY

3 Months Ended

Jun. 30, 2025

EARNING (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY [Abstract]

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY

2. EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings (Loss) Per Share

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):

 

	For the three months ended
	June 30,
	2025		2024
Basic earnings (loss) per share:
Net earnings (loss)	$	7,747	$	(7,489)
Basic weighted-average shares outstanding	65,448		66,621
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method (1)	1,283		—
Diluted weighted-average shares outstanding	66,731		66,621
Basic earnings (loss) per share:
Basic earnings (loss) per share:	$	0.12	$	(0.11)
Diluted earnings (loss) per share:
Diluted earnings (loss) per share:	$	0.12	$	(0.11)
Anti-dilutive equity awards under stock-based award plans excluded from the determination of diluted earnings per share	1,595		1,858
Earnings per share totals may not sum due to rounding.

(1) The number of common stock options and restricted stock units as computed under the treasury stock method that would have otherwise been dilutive but are excluded from the table above because their effect would have been anti-dilutive due to the net loss position of the Company was 1.8 million for the three months ended June 30, 2024.

Stockholders’ Equity

On August 14, 2024, the Company's board of directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $200.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.3 billion. In addition, it extended the common stock repurchase program duration through December 31, 2026.

During the three months ended June 30, 2025, the Company repurchased 1.1 million shares of its common stock for $29.9 million under the common stock repurchase program. Through June 30, 2025, the Company had repurchased a total of 42.6 million shares of its common stock for $1.1 billion under the program, leaving remaining capacity of $226.3 million.

Accumulated other comprehensive income balances of $6.1 million and $4.3 million at June 30, 2025 and March 31, 2025, respectively, reflect accumulated foreign currency translation adjustments.